| Medication Class | Before N (%) | After N (%) | % Change (before vs after) |
| Metformin | 207 (68.5) | 218 (72.2) | *5.4% increase |
| Sulfonylureas (glipizide, glimepiride, glyburide) | 121 (40.1) | 133 (44.0) | *9.7% increase |
| Thiazolidinediones (pioglitazone, rosiglitazone) | 56 (18.5) | 60 (19.8) | *7.0% increase |
| DPP-4 inhibitors (sitagliptin, saxagliptin, linagliptin) | 25 (8.3) | 34 (11.3) | *36.2% increase |
| GLP-1 agonists (exenatide, liraglutide) | 0 (0.0) | 0 (0.0) | No change |